









Markets
/
Stocks
/
nasdaq-sldb
/

Solid Biosciences Inc

SLDB

View Detailed Chart

6.930USD

+0.100+1.46%

Market hours （ET）Quotes delayed by 15 min

537.03MMarket Cap

LossP/E TTM



Solid Biosciences Inc

6.930

+0.100+1.46%

Overview Company Financials

Financials

Intraday

30m

Today

+1.46%

5 Days

-1.00%

1 Month

+37.77%

6 Months

+120.00%

Year to Date

+73.25%

1 Year

-11.72%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 13 analysts

BUY

Current Rating

15.909

Target Price

132.93%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

552

Total

Median

Average

Company name

Ratings

Analysts

Solid Biosciences Inc

SLDB

CRISPR Therapeutics AG

CRSP

Ionis Pharmaceuticals Inc

IONS

Intellia Therapeutics Inc

NTLA

Exact Sciences Corp

EXAS

IQVIA Holdings Inc

IQV

...

111

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Buy

Sell(3)

Neutral(3)

Buy(7)

Indicators

Sell(2)

Neutral(3)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

0.039

Buy

RSI(14)

69.296

Neutral

STOCH(KDJ)(9,3,3)

71.564

Neutral

ATR(14)

0.527

High Vlolatility

CCI(14)

35.882

Neutral

Williams %R

26.471

Buy

TRIX(12,20)

1.750

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(1)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MA5

6.966

Sell

MA10

6.787

Buy

MA20

6.142

Buy

MA50

4.979

Buy

MA100

4.284

Buy

MA200

4.528

Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Solid Biosciences Inc. is a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases. The Company is focused on advancing a portfolio of gene therapy candidates including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, AVB-401 for the treatment of BAG3-mediated dilated cardiomyopathy, and additional assets for the treatment of fatal cardiac diseases. The Company also has two cardiac pipeline gene transfer programs, SGT-601 for TNNT2 DCM and SGT-701 for RBM20 DCM, that are both in early preclinical development. It also has a neuromuscular gene transfer program for the treatment of Friedreich's ataxia. In addition to its gene transfer candidates, the Company has development programs focusing on platform technologies, including novel capsid libraries and dual gene expression, a technology that allows it to package multiple transgenes into one capsid.

Ticker SymbolSLDB

CompanySolid Biosciences Inc

CEOMr. Alexander (Bo) Cumbo

Websitehttps://www.solidbio.com/